ACAD ACADIA Pharmaceuticals | $15.21
-11.2% | 5/9/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $33.00 -> $27.00 | Low | View details for HC Wainwright rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 5/9/2024 |
VERV Verve Therapeutics | $6.36
+4.6% | 5/9/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Verve Therapeutics (NASDAQ:VERV) on 5/9/2024 |
LEGN Legend Biotech | $45.52
-0.4% | 5/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $87.00 | Low | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 5/9/2024 |
VCEL Vericel | $48.65
+2.0% | 5/9/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $53.00 -> $55.00 | Low | View details for HC Wainwright rating of Vericel (NASDAQ:VCEL) on 5/9/2024 |
PTGX Protagonist Therapeutics | $28.27
+4.3% | 5/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $38.00 | Low | View details for HC Wainwright rating of Protagonist Therapeutics (NASDAQ:PTGX) on 5/9/2024 |
VRDN Viridian Therapeutics | $13.91
-6.6% | 5/9/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $37.00 -> $27.00 | Low | View details for HC Wainwright rating of Viridian Therapeutics (NASDAQ:VRDN) on 5/9/2024 |
|
SANA Sana Biotechnology | $7.50
-21.0% | 5/9/2024 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Sana Biotechnology (NASDAQ:SANA) on 5/9/2024 |
RNAC Cartesian Therapeutics | $21.86
-6.0% | 5/9/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $54.00 | Low | View details for HC Wainwright rating of Cartesian Therapeutics (NASDAQ:RNAC) on 5/9/2024 |
AVDL Avadel Pharmaceuticals | $15.83
-2.6% | 5/9/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $25.00 -> $27.00 | Low | View details for HC Wainwright rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 5/9/2024 |
OLMA Olema Pharmaceuticals | $9.84
-9.3% | 5/9/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $25.00 -> $28.00 | Low | View details for HC Wainwright rating of Olema Pharmaceuticals (NASDAQ:OLMA) on 5/9/2024 |
PDSB PDS Biotechnology | $3.83
-4.7% | 5/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 | Low | View details for HC Wainwright rating of PDS Biotechnology (NASDAQ:PDSB) on 5/9/2024 |
FEMY Femasys | $1.27
-8.6% | 5/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $13.00 | Low | View details for HC Wainwright rating of Femasys (NASDAQ:FEMY) on 5/9/2024 |
IMCR Immunocore | $59.85
-2.4% | 5/9/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $90.00 -> $100.00 | Low | View details for HC Wainwright rating of Immunocore (NASDAQ:IMCR) on 5/9/2024 |
SLRN Acelyrin | $4.88
+1.9% | 5/9/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $28.00 -> $18.00 | Low | View details for HC Wainwright rating of Acelyrin (NASDAQ:SLRN) on 5/9/2024 |
PRTA Prothena | $22.00
-4.5% | 5/9/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $90.00 -> $84.00 | Low | View details for HC Wainwright rating of Prothena (NASDAQ:PRTA) on 5/9/2024 |
ALEC Alector | $5.20
+0.2% | 5/9/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $41.00 -> $35.00 | Low | View details for HC Wainwright rating of Alector (NASDAQ:ALEC) on 5/9/2024 |
CTMX CytomX Therapeutics | $2.04
-51.3% | 5/9/2024 | Reiterated by | HC Wainwright | - | Neutral | | Low | View details for HC Wainwright rating of CytomX Therapeutics (NASDAQ:CTMX) on 5/9/2024 |
BKSY BlackSky Technology | $1.21
+3.4% | 5/9/2024 | Reiterated by | HC Wainwright | Analyst S. Buck | Buy -> Buy | $2.50 | Low | View details for HC Wainwright rating of BlackSky Technology (NYSE:BKSY) on 5/9/2024 |
FTEK Fuel Tech | $1.31
+0.8% | 5/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $4.00 | Low | View details for HC Wainwright rating of Fuel Tech (NASDAQ:FTEK) on 5/9/2024 |
ASM Avino Silver & Gold Mines | $0.84
+16.9% | 5/9/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $1.60 -> $1.50 | Low | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 5/9/2024 |
ASM Avino Silver & Gold Mines | $0.84
+16.9% | 5/9/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $1.60 -> $1.50 | Low | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 5/9/2024 |
AG First Majestic Silver | $7.49
+5.3% | 5/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.50 | Low | View details for HC Wainwright rating of First Majestic Silver (NYSE:AG) on 5/9/2024 |
HL Hecla Mining | $5.48
+11.6% | 5/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.25 | Low | View details for HC Wainwright rating of Hecla Mining (NYSE:HL) on 5/9/2024 |
MIRM Mirum Pharmaceuticals | $25.83
+3.2% | 5/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $58.00 | Low | View details for HC Wainwright rating of Mirum Pharmaceuticals (NASDAQ:MIRM) on 5/9/2024 |
DVAX Dynavax Technologies | $11.01
-5.5% | 5/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $29.00 | Low | View details for HC Wainwright rating of Dynavax Technologies (NASDAQ:DVAX) on 5/9/2024 |
IFRX InflaRx | $1.20
| 5/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of InflaRx (NASDAQ:IFRX) on 5/9/2024 |
KPTI Karyopharm Therapeutics | $1.07
+4.9% | 5/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Karyopharm Therapeutics (NASDAQ:KPTI) on 5/9/2024 |
SNDX Syndax Pharmaceuticals | $21.97
-1.8% | 5/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $41.00 | Low | View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 5/9/2024 |
AVBP ArriVent BioPharma | $17.99
+3.6% | 5/9/2024 | Reiterated by | HC Wainwright | Analyst R. Burns | Buy -> Buy | $25.00 | Low | View details for HC Wainwright rating of ArriVent BioPharma (NASDAQ:AVBP) on 5/9/2024 |
TNGX Tango Therapeutics | $7.77
-1.8% | 5/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 | Low | View details for HC Wainwright rating of Tango Therapeutics (NASDAQ:TNGX) on 5/9/2024 |
BWAY BrainsWay | $5.45
-4.4% | 5/9/2024 | Target Raised by | HC Wainwright | Analyst B. Pachaiyappan | Buy -> Buy | $13.00 -> $15.00 | Low | View details for HC Wainwright rating of BrainsWay (NASDAQ:BWAY) on 5/9/2024 |
AQST Aquestive Therapeutics | $3.29
+6.8% | 5/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of Aquestive Therapeutics (NASDAQ:AQST) on 5/9/2024 |
PYPD PolyPid | $4.50
+4.4% | 5/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 | Low | View details for HC Wainwright rating of PolyPid (NASDAQ:PYPD) on 5/9/2024 |
CDXC ChromaDex | $3.52
-8.1% | 5/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of ChromaDex (NASDAQ:CDXC) on 5/9/2024 |
MRUS Merus | $45.12
-4.2% | 5/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $65.00 | Low | View details for HC Wainwright rating of Merus (NASDAQ:MRUS) on 5/9/2024 |
MYO Myomo | $3.56
-9.4% | 5/9/2024 | Reiterated by | HC Wainwright | Analyst S. Lee | Buy -> Buy | $6.50 | N/A | View details for HC Wainwright rating of Myomo (NYSEAMERICAN:MYO) on 5/9/2024 |
KMDA Kamada | $5.56
-3.1% | 5/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of Kamada (NASDAQ:KMDA) on 5/9/2024 |
ERAS Erasca | $1.96
-8.8% | 5/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Erasca (NASDAQ:ERAS) on 5/9/2024 |
KROS Keros Therapeutics | $57.60
-1.1% | 5/9/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $100.00 | Low | View details for HC Wainwright rating of Keros Therapeutics (NASDAQ:KROS) on 5/9/2024 |
NVCT Nuvectis Pharma | $6.38
-0.8% | 5/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 | Low | View details for HC Wainwright rating of Nuvectis Pharma (NASDAQ:NVCT) on 5/8/2024 |
BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (Ad) BREAKING - Pentagon to Spend $20 Billion on "Distributed AI"
The U.S. Space Force calls it a "game changer."
And one tiny firm is poised to win the contract to build it. Discover the name and ticker of this $2 stock here >>> |
QURE uniQure | $5.07
+3.7% | 5/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $25.00 | Low | View details for HC Wainwright rating of uniQure (NASDAQ:QURE) on 5/8/2024 |
APLS Apellis Pharmaceuticals | $42.52
+0.5% | 5/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $92.00 | Low | View details for HC Wainwright rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 5/8/2024 |
EOLS Evolus | $13.13
-1.0% | 5/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 | Low | View details for HC Wainwright rating of Evolus (NASDAQ:EOLS) on 5/8/2024 |
APLM Apollomics | $0.40
-4.8% | 5/8/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $5.00 -> $2.00 | Low | View details for HC Wainwright rating of Apollomics (NASDAQ:APLM) on 5/8/2024 |
MLTX MoonLake Immunotherapeutics | $41.97
-1.5% | 5/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $100.00 | Low | View details for HC Wainwright rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 5/8/2024 |
OCUL Ocular Therapeutix | $5.84
+1.6% | 5/8/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $16.00 -> $14.00 | Low | View details for HC Wainwright rating of Ocular Therapeutix (NASDAQ:OCUL) on 5/8/2024 |
DBVT DBV Technologies | $0.57
-17.4% | 5/8/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $10.00 -> $5.00 | Low | View details for HC Wainwright rating of DBV Technologies (NASDAQ:DBVT) on 5/8/2024 |
ZNTL Zentalis Pharmaceuticals | $12.52
+0.7% | 5/8/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $46.00 -> $40.00 | Low | View details for HC Wainwright rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 5/8/2024 |
PCRX Pacira BioSciences | $29.86
+0.7% | 5/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $57.00 | Low | View details for HC Wainwright rating of Pacira BioSciences (NASDAQ:PCRX) on 5/8/2024 |
PTN Palatin Technologies | $2.35
+14.6% | 5/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 | N/A | View details for HC Wainwright rating of Palatin Technologies (NYSEAMERICAN:PTN) on 5/8/2024 |
MDGL Madrigal Pharmaceuticals | $206.92
-0.5% | 5/8/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $425.00 -> $390.00 | Low | View details for HC Wainwright rating of Madrigal Pharmaceuticals (NASDAQ:MDGL) on 5/8/2024 |
CLNN Clene | $0.39
| 5/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 5/8/2024 |
CYTK Cytokinetics | $64.02
-1.9% | 5/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $94.00 | Low | View details for HC Wainwright rating of Cytokinetics (NASDAQ:CYTK) on 5/8/2024 |
DNLI Denali Therapeutics | $18.67
-1.2% | 5/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $95.00 | Low | View details for HC Wainwright rating of Denali Therapeutics (NASDAQ:DNLI) on 5/8/2024 |
OPK OPKO Health | $1.26
+0.8% | 5/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of OPKO Health (NASDAQ:OPK) on 5/8/2024 |
ESPR Esperion Therapeutics | $2.09
+2.5% | 5/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 | Low | View details for HC Wainwright rating of Esperion Therapeutics (NASDAQ:ESPR) on 5/8/2024 |
ARMP Armata Pharmaceuticals | $3.21
+16.3% | 5/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | N/A | View details for HC Wainwright rating of Armata Pharmaceuticals (NYSEAMERICAN:ARMP) on 5/8/2024 |
RIGL Rigel Pharmaceuticals | $1.02
+3.0% | 5/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Rigel Pharmaceuticals (NASDAQ:RIGL) on 5/8/2024 |
SRRK Scholar Rock | $14.55
+0.3% | 5/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Scholar Rock (NASDAQ:SRRK) on 5/8/2024 |
VIGL Vigil Neuroscience | $3.29
-13.0% | 5/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $24.00 | Low | View details for HC Wainwright rating of Vigil Neuroscience (NASDAQ:VIGL) on 5/8/2024 |
ARVN Arvinas | $31.95
-1.3% | 5/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $87.00 | Low | View details for HC Wainwright rating of Arvinas (NASDAQ:ARVN) on 5/8/2024 |
URG Ur-Energy | $1.80
+2.9% | 5/8/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $3.40 -> $3.30 | N/A | View details for HC Wainwright rating of Ur-Energy (NYSEAMERICAN:URG) on 5/8/2024 |
VALN Valneva | $7.12
-1.7% | 5/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $26.00 | Low | View details for HC Wainwright rating of Valneva (NASDAQ:VALN) on 5/8/2024 |
CRIS Curis | $16.51
+1.0% | 5/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $26.00 | Low | View details for HC Wainwright rating of Curis (NASDAQ:CRIS) on 5/8/2024 |
LGND Ligand Pharmaceuticals | $86.12
+7.2% | 5/8/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $144.00 | Low | View details for HC Wainwright rating of Ligand Pharmaceuticals (NASDAQ:LGND) on 5/8/2024 |
BNTX BioNTech | $92.06
+2.1% | 5/8/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $107.00 -> $113.00 | Low | View details for HC Wainwright rating of BioNTech (NASDAQ:BNTX) on 5/8/2024 |
GHRS GH Research | $11.99
| 5/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $40.00 | Low | View details for HC Wainwright rating of GH Research (NASDAQ:GHRS) on 5/7/2024 |
ENTA Enanta Pharmaceuticals | $12.93
+1.3% | 5/7/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $28.00 -> $27.00 | Low | View details for HC Wainwright rating of Enanta Pharmaceuticals (NASDAQ:ENTA) on 5/7/2024 |
CIFR Cipher Mining | $3.95
+4.8% | 5/7/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $4.50 -> $5.50 | Low | View details for HC Wainwright rating of Cipher Mining (NASDAQ:CIFR) on 5/7/2024 |
AGEN Agenus | $11.72
+2.2% | 5/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $40.00 | Low | View details for HC Wainwright rating of Agenus (NASDAQ:AGEN) on 5/7/2024 |
TVTX Travere Therapeutics | $6.60
-3.2% | 5/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $19.00 | Low | View details for HC Wainwright rating of Travere Therapeutics (NASDAQ:TVTX) on 5/7/2024 |
MRNS Marinus Pharmaceuticals | $1.39
-2.8% | 5/7/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $27.00 -> $11.00 | Low | View details for HC Wainwright rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 5/7/2024 |
ELDN Eledon Pharmaceuticals | $2.40
-1.6% | 5/7/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $13.00 -> $16.00 | Low | View details for HC Wainwright rating of Eledon Pharmaceuticals (NASDAQ:ELDN) on 5/7/2024 |
LBPH Longboard Pharmaceuticals | $21.99
+1.3% | 5/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $60.00 | Low | View details for HC Wainwright rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 5/7/2024 |
STOK Stoke Therapeutics | $12.01
+3.5% | 5/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $35.00 | Low | View details for HC Wainwright rating of Stoke Therapeutics (NASDAQ:STOK) on 5/7/2024 |
ALTO Alto Ingredients | $1.79
+4.1% | 5/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.50 | Low | View details for HC Wainwright rating of Alto Ingredients (NASDAQ:ALTO) on 5/7/2024 |
HALO Halozyme Therapeutics | $43.84
+4.4% | 5/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 5/7/2024 |
BCRX BioCryst Pharmaceuticals | $5.34
+4.7% | 5/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 5/7/2024 |
PLRX Pliant Therapeutics | $13.81
+3.0% | 5/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $36.00 | Low | View details for HC Wainwright rating of Pliant Therapeutics (NASDAQ:PLRX) on 5/7/2024 |
ZYME Zymeworks | $9.23
+1.9% | 5/7/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $10.00 | Low | View details for HC Wainwright rating of Zymeworks (NYSE:ZYME) on 5/7/2024 |
ADCT ADC Therapeutics | $4.57
+3.6% | 5/7/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $9.00 -> $8.00 | Low | View details for HC Wainwright rating of ADC Therapeutics (NYSE:ADCT) on 5/7/2024 |
AXSM Axsome Therapeutics | $73.68
-2.6% | 5/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $190.00 | Low | View details for HC Wainwright rating of Axsome Therapeutics (NASDAQ:AXSM) on 5/7/2024 |
RANI Rani Therapeutics | $6.78
-5.2% | 5/7/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $12.00 -> $13.00 | Low | View details for HC Wainwright rating of Rani Therapeutics (NASDAQ:RANI) on 5/7/2024 |
LYEL Lyell Immunopharma | $2.68
+7.2% | 5/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of Lyell Immunopharma (NASDAQ:LYEL) on 5/7/2024 |
FHTX Foghorn Therapeutics | $5.94
-0.7% | 5/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Foghorn Therapeutics (NASDAQ:FHTX) on 5/7/2024 |
DAWN Day One Biopharmaceuticals | $16.38
-0.2% | 5/7/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $50.00 -> $40.00 | Low | View details for HC Wainwright rating of Day One Biopharmaceuticals (NASDAQ:DAWN) on 5/7/2024 |
CLDX Celldex Therapeutics | $41.06
-0.4% | 5/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $80.00 | Low | View details for HC Wainwright rating of Celldex Therapeutics (NASDAQ:CLDX) on 5/7/2024 |
CTSO Cytosorbents | $0.81
-6.9% | 5/7/2024 | Reiterated by | HC Wainwright | Analyst S. Lee | Neutral -> Neutral | $1.00 | Low | View details for HC Wainwright rating of Cytosorbents (NASDAQ:CTSO) on 5/7/2024 |
GAU Galiano Gold | $1.71
-2.3% | 5/7/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $4.30 -> $4.40 | N/A | View details for HC Wainwright rating of Galiano Gold (NYSEAMERICAN:GAU) on 5/7/2024 |
VIR Vir Biotechnology | $9.56
+0.2% | 5/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $110.00 | Low | View details for HC Wainwright rating of Vir Biotechnology (NASDAQ:VIR) on 5/7/2024 |
Trump’s “Tax Free” Retirement Strategy (Ad) Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value.
In other words, a dollar back then would buy $17.82 worth of goods in today's money.
If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… |
ALNY Alnylam Pharmaceuticals | $151.37
-0.6% | 5/7/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $395.00 -> $400.00 | Low | View details for HC Wainwright rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 5/7/2024 |
VRTX Vertex Pharmaceuticals | $418.99
+0.0% | 5/7/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $462.00 | Low | View details for HC Wainwright rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 5/7/2024 |
MGX Metagenomi | $6.89
+1.3% | 5/7/2024 | Initiated by | HC Wainwright | Analyst M. Kapoor | Buy | $10.00 | Low | View details for HC Wainwright rating of Metagenomi (NASDAQ:MGX) on 5/7/2024 |
LYRA Lyra Therapeutics | $0.39
| 5/7/2024 | Downgraded by | HC Wainwright | Analyst M. Caufield | Buy -> Neutral | $12.00 -> $2.00 | Low | View details for HC Wainwright rating of Lyra Therapeutics (NASDAQ:LYRA) on 5/7/2024 |
KRYS Krystal Biotech | $158.74
+0.7% | 5/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $200.00 | Low | View details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 5/6/2024 |
GLYC GlycoMimetics | $0.30
| 5/6/2024 | Reiterated by | HC Wainwright | Analyst E. White | Buy -> Neutral | | N/A | View details for HC Wainwright rating of GlycoMimetics (NASDAQ:GLYC) on 5/6/2024 |
RGLS Regulus Therapeutics | $2.25
-0.9% | 5/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of Regulus Therapeutics (NASDAQ:RGLS) on 5/6/2024 |
GOSS Gossamer Bio | $0.75
-1.3% | 5/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Gossamer Bio (NASDAQ:GOSS) on 5/6/2024 |
LCTX Lineage Cell Therapeutics | $1.18
+1.7% | 5/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | N/A | View details for HC Wainwright rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 5/6/2024 |
VYNE VYNE Therapeutics | $2.65
-2.6% | 5/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.75 | Low | View details for HC Wainwright rating of VYNE Therapeutics (NASDAQ:VYNE) on 5/6/2024 |
VERU Veru | $1.37
-4.2% | 5/6/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $2.00 -> $3.00 | Low | View details for HC Wainwright rating of Veru (NASDAQ:VERU) on 5/6/2024 |
URGN UroGen Pharma | $12.97
-2.3% | 5/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $54.00 | Low | View details for HC Wainwright rating of UroGen Pharma (NASDAQ:URGN) on 5/6/2024 |
NR Newpark Resources | $7.65
+3.9% | 5/6/2024 | Reiterated by | HC Wainwright | Analyst A. Dayal | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Newpark Resources (NYSE:NR) on 5/6/2024 |
CRDF Cardiff Oncology | $3.38
+5.6% | 5/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 | Low | View details for HC Wainwright rating of Cardiff Oncology (NASDAQ:CRDF) on 5/6/2024 |
BCPC Balchem | $155.02
+1.1% | 5/6/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $167.00 -> $170.00 | Low | View details for HC Wainwright rating of Balchem (NASDAQ:BCPC) on 5/6/2024 |
SAND Sandstorm Gold | $5.73
+2.3% | 5/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of Sandstorm Gold (NYSE:SAND) on 5/6/2024 |
SWTX SpringWorks Therapeutics | $42.95
+1.6% | 5/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $74.00 | Low | View details for HC Wainwright rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 5/6/2024 |
ALDX Aldeyra Therapeutics | $3.94
-3.2% | 5/6/2024 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 5/6/2024 |
TARA Protara Therapeutics | $2.98
+5.3% | 5/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $23.00 | Low | View details for HC Wainwright rating of Protara Therapeutics (NASDAQ:TARA) on 5/6/2024 |
AEON AEON Biopharma | $1.66
-6.2% | 5/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 | Low | View details for HC Wainwright rating of AEON Biopharma (NASDAQ:AEON) on 5/6/2024 |
CGON CG Oncology | $30.02
-7.4% | 5/6/2024 | Reiterated by | HC Wainwright | Analyst A. Maldonado | Buy -> Buy | $75.00 | Low | View details for HC Wainwright rating of CG Oncology (NASDAQ:CGON) on 5/6/2024 |
HOWL Werewolf Therapeutics | $5.57
+1.6% | 5/6/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Werewolf Therapeutics (NASDAQ:HOWL) on 5/6/2024 |
FNV Franco-Nevada | $127.38
+0.8% | 5/6/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $175.00 -> $185.00 | Low | View details for HC Wainwright rating of Franco-Nevada (NYSE:FNV) on 5/6/2024 |
JSPR Jasper Therapeutics | $21.42
+1.1% | 5/6/2024 | Initiated by | HC Wainwright | Analyst E. Bodnar | Buy | $65.00 | Low | View details for HC Wainwright rating of Jasper Therapeutics (NASDAQ:JSPR) on 5/6/2024 |
EU enCore Energy | $4.88
+3.2% | 5/6/2024 | Initiated by | HC Wainwright | Analyst H. Ihle | Buy | $7.50 | Low | View details for HC Wainwright rating of enCore Energy (NASDAQ:EU) on 5/6/2024 |
PBYI Puma Biotechnology | $4.79
-0.8% | 5/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Puma Biotechnology (NASDAQ:PBYI) on 5/3/2024 |
BCYC Bicycle Therapeutics | $23.58
-0.2% | 5/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $55.00 | Low | View details for HC Wainwright rating of Bicycle Therapeutics (NASDAQ:BCYC) on 5/3/2024 |
JAZZ Jazz Pharmaceuticals | $113.12
+2.2% | 5/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $200.00 | Low | View details for HC Wainwright rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 5/3/2024 |
KALV KalVista Pharmaceuticals | $12.09
+0.2% | 5/3/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $24.00 -> $20.00 | Low | View details for HC Wainwright rating of KalVista Pharmaceuticals (NASDAQ:KALV) on 5/3/2024 |
DYN Dyne Therapeutics | $25.95
+1.0% | 5/3/2024 | Reiterated by | HC Wainwright | Analyst A. Fein | Buy -> Buy | $36.00 | Low | View details for HC Wainwright rating of Dyne Therapeutics (NASDAQ:DYN) on 5/3/2024 |
BMEA Biomea Fusion | $11.44
+3.3% | 5/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Biomea Fusion (NASDAQ:BMEA) on 5/3/2024 |
KURA Kura Oncology | $20.77
+1.1% | 5/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $32.00 | Low | View details for HC Wainwright rating of Kura Oncology (NASDAQ:KURA) on 5/3/2024 |
LIFE aTyr Pharma | $1.72
+1.8% | 5/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $35.00 | Low | View details for HC Wainwright rating of aTyr Pharma (NASDAQ:LIFE) on 5/3/2024 |
SCLX Scilex | $0.83
-2.4% | 5/3/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $12.00 -> $8.00 | Low | View details for HC Wainwright rating of Scilex (NASDAQ:SCLX) on 5/3/2024 |
KRON Kronos Bio | $1.05
+1.0% | 5/3/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $2.50 -> $2.25 | Low | View details for HC Wainwright rating of Kronos Bio (NASDAQ:KRON) on 5/3/2024 |
EXEL Exelixis | $21.76
+0.8% | 5/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $28.00 | Low | View details for HC Wainwright rating of Exelixis (NASDAQ:EXEL) on 5/3/2024 |
NGNE Neurogene | $33.21
+0.9% | 5/3/2024 | Reiterated by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $55.00 | Low | View details for HC Wainwright rating of Neurogene (NASDAQ:NGNE) on 5/3/2024 |
NXTC NextCure | $1.72
+8.9% | 5/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of NextCure (NASDAQ:NXTC) on 5/3/2024 |
BPMC Blueprint Medicines | $108.34
-0.4% | 5/3/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $125.00 -> $135.00 | Low | View details for HC Wainwright rating of Blueprint Medicines (NASDAQ:BPMC) on 5/3/2024 |
XPL Solitario Resources | $0.78
-2.5% | 5/3/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $0.80 -> $1.10 | N/A | View details for HC Wainwright rating of Solitario Resources (NYSEAMERICAN:XPL) on 5/3/2024 |
BBAI BigBear.ai | $1.48
-0.7% | 5/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.00 | Low | View details for HC Wainwright rating of BigBear.ai (NYSE:BBAI) on 5/3/2024 |
GEVO Gevo | $0.76
+1.3% | 5/3/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 | Low | View details for HC Wainwright rating of Gevo (NASDAQ:GEVO) on 5/3/2024 |
ASPN Aspen Aerogels | $26.73
+0.4% | 5/3/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $20.00 -> $25.00 | Low | View details for HC Wainwright rating of Aspen Aerogels (NYSE:ASPN) on 5/3/2024 |
STTK Shattuck Labs | $10.66
+1.6% | 5/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $28.00 | Low | View details for HC Wainwright rating of Shattuck Labs (NASDAQ:STTK) on 5/2/2024 |
PTN Palatin Technologies | $2.35
+14.6% | 5/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 | N/A | View details for HC Wainwright rating of Palatin Technologies (NYSEAMERICAN:PTN) on 5/2/2024 |
TGTX TG Therapeutics | $16.92
-1.2% | 5/2/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $45.00 -> $49.00 | Low | View details for HC Wainwright rating of TG Therapeutics (NASDAQ:TGTX) on 5/2/2024 |
ALKS Alkermes | $24.26
+0.7% | 5/2/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $35.00 | Low | View details for HC Wainwright rating of Alkermes (NASDAQ:ALKS) on 5/2/2024 |
NERV Minerva Neurosciences | $2.51
| 5/2/2024 | Target Lowered by | HC Wainwright | - | Neutral -> Neutral | $11.00 -> $7.00 | Low | View details for HC Wainwright rating of Minerva Neurosciences (NASDAQ:NERV) on 5/2/2024 |
CORT Corcept Therapeutics | $26.60
+4.7% | 5/2/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $38.00 -> $40.00 | Low | View details for HC Wainwright rating of Corcept Therapeutics (NASDAQ:CORT) on 5/2/2024 |
PSTX Poseida Therapeutics | $2.71
| 5/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Poseida Therapeutics (NASDAQ:PSTX) on 5/2/2024 |
Trump’s “Tax Free” Retirement Strategy (Ad) Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value.
In other words, a dollar back then would buy $17.82 worth of goods in today's money.
If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… |
GTHX G1 Therapeutics | $4.98
+16.1% | 5/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of G1 Therapeutics (NASDAQ:GTHX) on 5/2/2024 |
NVCR NovoCure | $16.13
+0.6% | 5/2/2024 | Target Lowered by | HC Wainwright | - | Neutral -> Neutral | $24.00 -> $22.00 | Low | View details for HC Wainwright rating of NovoCure (NASDAQ:NVCR) on 5/2/2024 |
UTHR United Therapeutics | $266.05
+1.9% | 5/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $300.00 | Low | View details for HC Wainwright rating of United Therapeutics (NASDAQ:UTHR) on 5/2/2024 |
NBIX Neurocrine Biosciences | $139.66
+0.5% | 5/2/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $150.00 -> $160.00 | Low | View details for HC Wainwright rating of Neurocrine Biosciences (NASDAQ:NBIX) on 5/2/2024 |
BLCO Bausch + Lomb | $15.28
+3.2% | 5/2/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Bausch + Lomb (NYSE:BLCO) on 5/2/2024 |
SGMT Sagimet Biosciences | $4.57
+2.9% | 5/2/2024 | Initiated by | HC Wainwright | Analyst E. Arce | Buy | $32.00 | Low | View details for HC Wainwright rating of Sagimet Biosciences (NASDAQ:SGMT) on 5/2/2024 |
RIOT Riot Platforms | $10.28
-0.7% | 5/1/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $20.00 -> $17.00 | N/A | View details for HC Wainwright rating of Riot Platforms (NASDAQ:RIOT) on 5/1/2024 |
LGO Largo | $1.65
+5.8% | 5/1/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $4.60 -> $4.70 | Low | View details for HC Wainwright rating of Largo (NYSE:LGO) on 5/1/2024 |
CYTH Cyclo Therapeutics | $1.45
-3.3% | 5/1/2024 | Initiated by | HC Wainwright | Analyst S. Ramakanth | Buy | $3.00 | Low | View details for HC Wainwright rating of Cyclo Therapeutics (NASDAQ:CYTH) on 5/1/2024 |
PYPD PolyPid | $4.50
+4.4% | 5/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $14.00 | Low | View details for HC Wainwright rating of PolyPid (NASDAQ:PYPD) on 5/1/2024 |
LYRA Lyra Therapeutics | $0.39
| 5/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Lyra Therapeutics (NASDAQ:LYRA) on 5/1/2024 |
ZYXI Zynex | $10.34
-3.6% | 5/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 | Low | View details for HC Wainwright rating of Zynex (NASDAQ:ZYXI) on 5/1/2024 |
CECO CECO Environmental | $24.62
+0.7% | 5/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of CECO Environmental (NASDAQ:CECO) on 5/1/2024 |
XOMA XOMA | $23.69
-2.1% | 5/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $74.00 | Low | View details for HC Wainwright rating of XOMA (NASDAQ:XOMA) on 5/1/2024 |
DARE Daré Bioscience | $0.31
+3.3% | 5/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of Daré Bioscience (NASDAQ:DARE) on 5/1/2024 |
MDXG MiMedx Group | $7.24
+0.6% | 5/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $11.00 | Low | View details for HC Wainwright rating of MiMedx Group (NASDAQ:MDXG) on 5/1/2024 |
FHTX Foghorn Therapeutics | $5.94
-0.7% | 5/1/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Foghorn Therapeutics (NASDAQ:FHTX) on 5/1/2024 |
TERN Terns Pharmaceuticals | $5.86
-3.1% | 4/30/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $5.50 | Low | View details for HC Wainwright rating of Terns Pharmaceuticals (NASDAQ:TERN) on 4/30/2024 |
OMGA Omega Therapeutics | $2.17
+0.9% | 4/30/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $12.00 | Low | View details for HC Wainwright rating of Omega Therapeutics (NASDAQ:OMGA) on 4/30/2024 |
GMAB Genmab A/S | $28.81
+0.0% | 4/30/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 4/30/2024 |
ANVS Annovis Bio | $6.03
+25.1% | 4/30/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Annovis Bio (NYSE:ANVS) on 4/30/2024 |
AQST Aquestive Therapeutics | $3.29
+6.8% | 4/30/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of Aquestive Therapeutics (NASDAQ:AQST) on 4/30/2024 |
HALO Halozyme Therapeutics | $43.84
+4.4% | 4/30/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 4/30/2024 |
ITRM Iterum Therapeutics | $1.61
+0.6% | 4/30/2024 | Reiterated by | HC Wainwright | Analyst E. Arce | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of Iterum Therapeutics (NASDAQ:ITRM) on 4/30/2024 |
EKSO Ekso Bionics | $1.26
-8.7% | 4/30/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $9.25 -> $10.00 | Low | View details for HC Wainwright rating of Ekso Bionics (NASDAQ:EKSO) on 4/30/2024 |
XFOR X4 Pharmaceuticals | $1.07
+1.9% | 4/30/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $3.00 -> $5.00 | Low | View details for HC Wainwright rating of X4 Pharmaceuticals (NASDAQ:XFOR) on 4/30/2024 |
NBTX Nanobiotix | $6.67
-3.3% | 4/26/2024 | Reiterated by | HC Wainwright | Analyst S. Ramakanth | Buy | | Low | View details for HC Wainwright rating of Nanobiotix (NASDAQ:NBTX) on 4/26/2024 |
AVBP ArriVent BioPharma | $17.99
+3.6% | 4/30/2024 | Initiated by | HC Wainwright | Analyst R. Burns | Buy | $25.00 | Low | View details for HC Wainwright rating of ArriVent BioPharma (NASDAQ:AVBP) on 4/30/2024 |
ADVM Adverum Biotechnologies | $9.61
-2.0% | 4/30/2024 | Initiated by | HC Wainwright | Analyst M. Caufield | Buy | $30.00 | Low | View details for HC Wainwright rating of Adverum Biotechnologies (NASDAQ:ADVM) on 4/30/2024 |
GAU Galiano Gold | $1.71
-2.3% | 4/29/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $2.20 -> $4.30 | N/A | View details for HC Wainwright rating of Galiano Gold (NYSEAMERICAN:GAU) on 4/29/2024 |
COIN Coinbase Global | $210.45
-0.4% | 4/29/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $250.00 -> $300.00 | Low | View details for HC Wainwright rating of Coinbase Global (NASDAQ:COIN) on 4/29/2024 |
ATNM Actinium Pharmaceuticals | $8.90
+2.2% | 4/29/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | N/A | View details for HC Wainwright rating of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) on 4/29/2024 |
OVID Ovid Therapeutics | $3.05
-1.3% | 4/29/2024 | Initiated by | HC Wainwright | Analyst R. Selvaraju | Buy | $9.00 | Low | View details for HC Wainwright rating of Ovid Therapeutics (NASDAQ:OVID) on 4/29/2024 |
OPTN OptiNose | $1.12
+7.7% | 4/29/2024 | Reiterated by | HC Wainwright | Analyst M. Caufield | Buy -> Buy | $5.00 | Low | View details for HC Wainwright rating of OptiNose (NASDAQ:OPTN) on 4/29/2024 |
SAGE Sage Therapeutics | $12.34
-0.4% | 4/26/2024 | Target Lowered by | HC Wainwright | - | Neutral -> Neutral | $28.00 -> $25.00 | Low | View details for HC Wainwright rating of Sage Therapeutics (NASDAQ:SAGE) on 4/26/2024 |
APLS Apellis Pharmaceuticals | $42.52
+0.5% | 4/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $92.00 | Low | View details for HC Wainwright rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 4/26/2024 |
PPBT Purple Biotech | $0.53
-3.6% | 4/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Purple Biotech (NASDAQ:PPBT) on 4/26/2024 |
HOOK Hookipa Pharma | $0.80
| 4/26/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $6.50 -> $5.00 | Low | View details for HC Wainwright rating of Hookipa Pharma (NASDAQ:HOOK) on 4/26/2024 |
BPMC Blueprint Medicines | $108.34
-0.4% | 4/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $125.00 | Low | View details for HC Wainwright rating of Blueprint Medicines (NASDAQ:BPMC) on 4/26/2024 |
PRAX Praxis Precision Medicines | $50.09
-1.3% | 4/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $105.00 | Low | View details for HC Wainwright rating of Praxis Precision Medicines (NASDAQ:PRAX) on 4/26/2024 |
SNDX Syndax Pharmaceuticals | $21.97
-1.8% | 4/26/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $41.00 | Low | View details for HC Wainwright rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 4/26/2024 |
ARBK Argo Blockchain | $1.37
+1.5% | 4/26/2024 | Downgraded by | HC Wainwright | Analyst K. Dede | Buy -> Neutral | | Low | View details for HC Wainwright rating of Argo Blockchain (NASDAQ:ARBK) on 4/26/2024 |
LSTA Lisata Therapeutics | $2.91
+5.8% | 4/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $15.00 | Low | View details for HC Wainwright rating of Lisata Therapeutics (NASDAQ:LSTA) on 4/25/2024 |
MAG MAG Silver | $13.08
+3.7% | 4/25/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $16.00 -> $17.00 | N/A | View details for HC Wainwright rating of MAG Silver (NYSEAMERICAN:MAG) on 4/25/2024 |
URG Ur-Energy | $1.80
+2.9% | 4/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $3.60 -> $3.40 | N/A | View details for HC Wainwright rating of Ur-Energy (NYSEAMERICAN:URG) on 4/25/2024 |
LTRN Lantern Pharma | $6.81
+5.1% | 4/25/2024 | Reiterated by | HC Wainwright | - | Neutral | | Low | View details for HC Wainwright rating of Lantern Pharma (NASDAQ:LTRN) on 4/25/2024 |
GANX Gain Therapeutics | $2.54
-5.2% | 4/25/2024 | Reiterated by | HC Wainwright | Analyst R. Selvaraju | Buy -> Buy | $9.00 | Low | View details for HC Wainwright rating of Gain Therapeutics (NASDAQ:GANX) on 4/25/2024 |
EVO Evotec | $5.27
+1.5% | 4/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $14.00 -> $11.00 | Low | View details for HC Wainwright rating of Evotec (NASDAQ:EVO) on 4/25/2024 |
VKTX Viking Therapeutics | $80.20
+0.4% | 4/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $90.00 | Low | View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 4/25/2024 |
XOMA XOMA | $23.69
-2.1% | 4/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $74.00 | Low | View details for HC Wainwright rating of XOMA (NASDAQ:XOMA) on 4/25/2024 |
Proof that the Musk/Bezos rivalry is about to hit a new level (Ad) Elon Musk Humiliated
Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats… Go here now for full story. |
CAPR Capricor Therapeutics | $5.42
+0.9% | 4/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $40.00 | Low | View details for HC Wainwright rating of Capricor Therapeutics (NASDAQ:CAPR) on 4/25/2024 |
ACRV Acrivon Therapeutics | $8.14
-1.1% | 4/25/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Acrivon Therapeutics (NASDAQ:ACRV) on 4/25/2024 |
BIIB Biogen | $222.75
+1.4% | 4/25/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $325.00 -> $300.00 | Low | View details for HC Wainwright rating of Biogen (NASDAQ:BIIB) on 4/25/2024 |
TVTX Travere Therapeutics | $6.60
-3.2% | 4/24/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $17.00 -> $19.00 | Low | View details for HC Wainwright rating of Travere Therapeutics (NASDAQ:TVTX) on 4/24/2024 |
NBIX Neurocrine Biosciences | $139.66
+0.5% | 4/24/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $150.00 | Low | View details for HC Wainwright rating of Neurocrine Biosciences (NASDAQ:NBIX) on 4/24/2024 |
DAWN Day One Biopharmaceuticals | $16.38
-0.2% | 4/24/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | Low | View details for HC Wainwright rating of Day One Biopharmaceuticals (NASDAQ:DAWN) on 4/24/2024 |
CLIR ClearSign Technologies | $0.80
-1.2% | 4/24/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of ClearSign Technologies (NASDAQ:CLIR) on 4/24/2024 |
AEYE AudioEye | $18.12
-3.0% | 4/24/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $17.00 | Low | View details for HC Wainwright rating of AudioEye (NASDAQ:AEYE) on 4/24/2024 |
OCS Oculis | $11.95
-3.4% | 4/24/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $29.00 -> $28.00 | Low | View details for HC Wainwright rating of Oculis (NASDAQ:OCS) on 4/24/2024 |
CORT Corcept Therapeutics | $26.60
+4.7% | 4/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $38.00 | Low | View details for HC Wainwright rating of Corcept Therapeutics (NASDAQ:CORT) on 4/23/2024 |
GROY Gold Royalty | $1.85
+3.4% | 4/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $5.75 | N/A | View details for HC Wainwright rating of Gold Royalty (NYSEAMERICAN:GROY) on 4/23/2024 |
LEGN Legend Biotech | $45.52
-0.4% | 4/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $87.00 | Low | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 4/23/2024 |
ATXS Astria Therapeutics | $10.17
+6.3% | 4/23/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $18.00 -> $16.00 | Low | View details for HC Wainwright rating of Astria Therapeutics (NASDAQ:ATXS) on 4/23/2024 |
MLTX MoonLake Immunotherapeutics | $41.97
-1.5% | 4/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $100.00 | Low | View details for HC Wainwright rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 4/23/2024 |
BTAI BioXcel Therapeutics | $2.31
+9.0% | 4/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of BioXcel Therapeutics (NASDAQ:BTAI) on 4/23/2024 |
ENLV Enlivex Therapeutics | $1.52
-1.9% | 4/23/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Enlivex Therapeutics (NASDAQ:ENLV) on 4/23/2024 |
RNAC Cartesian Therapeutics | $21.86
-6.0% | 4/23/2024 | Target Raised by | HC Wainwright | Analyst M. Kapoor | Buy -> Buy | $2.00 -> $54.00 | Low | View details for HC Wainwright rating of Cartesian Therapeutics (NASDAQ:RNAC) on 4/23/2024 |
KURA Kura Oncology | $20.77
+1.1% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $32.00 | Low | View details for HC Wainwright rating of Kura Oncology (NASDAQ:KURA) on 4/22/2024 |
RIOT Riot Platforms | $10.28
-0.7% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | N/A | View details for HC Wainwright rating of Riot Platforms (NASDAQ:RIOT) on 4/22/2024 |
KRYS Krystal Biotech | $158.74
+0.7% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $200.00 | Low | View details for HC Wainwright rating of Krystal Biotech (NASDAQ:KRYS) on 4/22/2024 |
CRDL Cardiol Therapeutics | C$3.03
+10.2% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy | | N/A | View details for HC Wainwright rating of Cardiol Therapeutics (TSE:CRDL) on 4/22/2024 |
CLMT Calumet Specialty Products Partners | $16.16
+0.3% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $25.00 | Low | View details for HC Wainwright rating of Calumet Specialty Products Partners (NASDAQ:CLMT) on 4/22/2024 |
RVPH Reviva Pharmaceuticals | $2.14
-24.1% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Reviva Pharmaceuticals (NASDAQ:RVPH) on 4/22/2024 |
LYTS LSI Industries | $16.07
+1.3% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of LSI Industries (NASDAQ:LYTS) on 4/22/2024 |
PHGE BiomX | $0.36
-2.7% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $2.00 | N/A | View details for HC Wainwright rating of BiomX (NYSEMKT:PHGE) on 4/22/2024 |
ROIV Roivant Sciences | $11.25
+0.4% | 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 | Low | View details for HC Wainwright rating of Roivant Sciences (NASDAQ:ROIV) on 4/22/2024 |
PSTX Poseida Therapeutics | $2.71
| 4/22/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $20.00 | Low | View details for HC Wainwright rating of Poseida Therapeutics (NASDAQ:PSTX) on 4/22/2024 |
CRDL Cardiol Therapeutics | $2.21
+10.5% | 4/22/2024 | Initiated by | HC Wainwright | Analyst V. Bernardino | Buy | $9.00 | Low | View details for HC Wainwright rating of Cardiol Therapeutics (NASDAQ:CRDL) on 4/22/2024 |
BRNS Barinthus Biotherapeutics | $2.35
+3.5% | 4/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $8.00 | Low | View details for HC Wainwright rating of Barinthus Biotherapeutics (NASDAQ:BRNS) on 4/19/2024 |
AG First Majestic Silver | $7.49
+5.3% | 4/19/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $7.00 -> $8.50 | Low | View details for HC Wainwright rating of First Majestic Silver (NYSE:AG) on 4/19/2024 |
ALKS Alkermes | $24.26
+0.7% | 4/19/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $35.00 | Low | View details for HC Wainwright rating of Alkermes (NASDAQ:ALKS) on 4/19/2024 |
OCUL Ocular Therapeutix | $5.84
+1.6% | 4/19/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $16.00 | Low | View details for HC Wainwright rating of Ocular Therapeutix (NASDAQ:OCUL) on 4/19/2024 |
TGTX TG Therapeutics | $16.92
-1.2% | 4/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $45.00 | Low | View details for HC Wainwright rating of TG Therapeutics (NASDAQ:TGTX) on 4/18/2024 |
URGN UroGen Pharma | $12.97
-2.3% | 4/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $54.00 | Low | View details for HC Wainwright rating of UroGen Pharma (NASDAQ:URGN) on 4/18/2024 |
BEEM Beam Global | $6.25
-0.8% | 4/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $30.00 | Low | View details for HC Wainwright rating of Beam Global (NASDAQ:BEEM) on 4/18/2024 |
IGMS IGM Biosciences | $10.12
+8.4% | 4/18/2024 | Reiterated by | HC Wainwright | Analyst R. Burns | Neutral -> Neutral | $12.00 | Low | View details for HC Wainwright rating of IGM Biosciences (NASDAQ:IGMS) on 4/18/2024 |
ASM Avino Silver & Gold Mines | $0.84
+16.9% | 4/18/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $1.50 -> $1.60 | Low | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 4/18/2024 |
ASM Avino Silver & Gold Mines | $0.84
+16.9% | 4/18/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $1.50 -> $1.60 | Low | View details for HC Wainwright rating of Avino Silver & Gold Mines (NYSE:ASM) on 4/18/2024 |
ARGX argenx | $382.55
-0.9% | 4/18/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $451.00 | Low | View details for HC Wainwright rating of argenx (NASDAQ:ARGX) on 4/18/2024 |
AEYE AudioEye | $18.12
-3.0% | 4/18/2024 | Target Raised by | HC Wainwright | - | Buy -> Buy | $10.00 -> $17.00 | Low | View details for HC Wainwright rating of AudioEye (NASDAQ:AEYE) on 4/18/2024 |
ASND Ascendant Resources | C$0.07
-13.3% | 4/17/2024 | Target Raised by | HC Wainwright | - | | C$0.30 -> C$0.35 | N/A | View details for HC Wainwright rating of Ascendant Resources (TSE:ASND) on 4/17/2024 |
BNTX BioNTech | $92.06
+2.1% | 4/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $107.00 | Low | View details for HC Wainwright rating of BioNTech (NASDAQ:BNTX) on 4/17/2024 |
ASPI ASP Isotopes | $3.63
+0.3% | 4/17/2024 | Target Raised by | HC Wainwright | Analyst H. Ihle | Buy -> Buy | $5.25 -> $5.50 | Low | View details for HC Wainwright rating of ASP Isotopes (NASDAQ:ASPI) on 4/17/2024 |
CNTB Connect Biopharma | $1.43
-1.4% | 4/17/2024 | Target Raised by | HC Wainwright | Analyst E. Bodnar | Buy -> Buy | $7.00 -> $8.00 | Low | View details for HC Wainwright rating of Connect Biopharma (NASDAQ:CNTB) on 4/17/2024 |
CLNN Clene | $0.39
| 4/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $7.00 | Low | View details for HC Wainwright rating of Clene (NASDAQ:CLNN) on 4/17/2024 |
AEON AEON Biopharma | $1.66
-6.2% | 4/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $18.00 | Low | View details for HC Wainwright rating of AEON Biopharma (NASDAQ:AEON) on 4/17/2024 |
CLDX Celldex Therapeutics | $41.06
-0.4% | 4/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $80.00 | N/A | View details for HC Wainwright rating of Celldex Therapeutics (NASDAQ:CLDX) on 4/17/2024 |
HALO Halozyme Therapeutics | $43.84
+4.4% | 4/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $50.00 | N/A | View details for HC Wainwright rating of Halozyme Therapeutics (NASDAQ:HALO) on 4/17/2024 |
SAGE Sage Therapeutics | $12.34
-0.4% | 4/17/2024 | Reiterated by | HC Wainwright | - | Neutral -> Neutral | $28.00 | N/A | View details for HC Wainwright rating of Sage Therapeutics (NASDAQ:SAGE) on 4/17/2024 |
DTIL Precision BioSciences | $10.93
-3.0% | 4/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $60.00 | N/A | View details for HC Wainwright rating of Precision BioSciences (NASDAQ:DTIL) on 4/17/2024 |
BLRX BioLineRx | $0.69
+4.6% | 4/17/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $21.00 | N/A | View details for HC Wainwright rating of BioLineRx (NASDAQ:BLRX) on 4/17/2024 |
SABS SAB Biotherapeutics | $4.00
-2.4% | 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $6.00 | Low | View details for HC Wainwright rating of SAB Biotherapeutics (NASDAQ:SABS) on 4/16/2024 |
CMPX Compass Therapeutics | $1.59
+0.6% | 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $10.00 | Low | View details for HC Wainwright rating of Compass Therapeutics (NASDAQ:CMPX) on 4/16/2024 |
CGEM Cullinan Oncology | $27.17
-2.0% | 4/16/2024 | Target Lowered by | HC Wainwright | - | Buy -> Buy | $34.00 -> $29.00 | Low | View details for HC Wainwright rating of Cullinan Oncology (NASDAQ:CGEM) on 4/16/2024 |
LEGN Legend Biotech | $45.52
-0.4% | 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $87.00 | Low | View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 4/16/2024 |
MRNS Marinus Pharmaceuticals | $1.39
-2.8% | 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $27.00 | Low | View details for HC Wainwright rating of Marinus Pharmaceuticals (NASDAQ:MRNS) on 4/16/2024 |
ATOS Atossa Therapeutics | $1.69
+0.6% | 4/16/2024 | Reiterated by | HC Wainwright | Analyst E. Bodnar | Buy -> Buy | $4.00 | Low | View details for HC Wainwright rating of Atossa Therapeutics (NASDAQ:ATOS) on 4/16/2024 |
ICCM IceCure Medical | $1.17
| 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $3.00 | Low | View details for HC Wainwright rating of IceCure Medical (NASDAQ:ICCM) on 4/16/2024 |
TRNS Transcat | $117.37
+1.9% | 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $124.00 | Low | View details for HC Wainwright rating of Transcat (NASDAQ:TRNS) on 4/16/2024 |
MITK Mitek Systems | $13.38
| 4/16/2024 | Reiterated by | HC Wainwright | - | Buy -> Buy | $19.00 | Low | View details for HC Wainwright rating of Mitek Systems (NASDAQ:MITK) on 4/16/2024 |
